Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Granulomatous disease in common variable immunodeficiency.

Yoshikazu Morimoto1, John M Routes

  • 1Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson Street, Denver, CO 80206, USA.

Current Allergy and Asthma Reports
|August 11, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.

Lancet (London, England)·2023
Same author

Impaired Response to Polysaccharide Vaccine in Selective IgE Deficiency.

Journal of clinical immunology·2023
Same author

Dysregulated Lymphocyte Antigen Receptor Signaling in Common Variable Immunodeficiency with Granulomatous Lymphocytic Interstitial Lung Disease.

Journal of clinical immunology·2023
Same author

Constrained chromatin accessibility in PU.1-mutated agammaglobulinemia patients.

The Journal of experimental medicine·2021
Same author

Safety and Tolerability of Subcutaneous IgPro20 at High Infusion Parameters in Patients with Primary Immunodeficiency: Findings from the Pump-Assisted Administration Cohorts of the HILO Study.

Journal of clinical immunology·2021
Same author

Correction: Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT.

Journal of clinical immunology·2020
Same journal

Harnessing Machine Learning and Electronic Health Record Data to Improve Asthma Management.

Current allergy and asthma reports·2026
Same journal

Incorporating New Guidelines into School-Based Asthma Management.

Current allergy and asthma reports·2026
Same journal

The Modern Environment and Childhood Asthma: The Role of Air Pollution and Heavy Metal Exposure.

Current allergy and asthma reports·2026
Same journal

Targeting Type 2 and Non-type 2 Asthma: Emerging Biologics and Personalized Strategies.

Current allergy and asthma reports·2026
Same journal

The Role of the Indoor Exposome in Food Allergy Development.

Current allergy and asthma reports·2026
Same journal

Understanding Infantile Atopic Dermatitis: A Review of Environmental, Familial, Genetic and Microbial Influences.

Current allergy and asthma reports·2026
See all related articles

Common variable immunodeficiency (CVID) can cause multisystemic granulomatous disease, affecting organs like the lungs and leading to serious health issues. The exact cause and best treatments for CVID-associated granulomatous disease require further investigation.

Area of Science:

  • Immunology
  • Pulmonology
  • Rheumatology

Background:

  • Common variable immunodeficiency (CVID) is a primary immunodeficiency with unknown causes, marked by low IgG, poor antibody response, and T-cell issues.
  • Multisystemic granulomatous disease is a known complication of CVID, significantly increasing morbidity and mortality.
  • Granulomas in CVID commonly affect the lungs but also frequently appear in the skin, liver, spleen, and gastrointestinal tract.

Purpose of the Study:

  • To review the characteristics of granulomatous disease in patients with CVID.
  • To highlight the association between CVID and granulomatous disease, including its multisystemic nature.
  • To emphasize the need for further research into the etiology and treatment of CVID-associated granulomatous disease.

Main Methods:

Related Experiment Videos

  • Review of existing literature on CVID and granulomatous disease.
  • Analysis of clinical, radiographic, and laboratory findings in affected patients.
  • Synthesis of information regarding complications, associated disorders, and treatment challenges.

Main Results:

  • Granulomatous disease in CVID presents with multisystemic involvement, frequently affecting the lungs, liver, spleen, skin, and GI tract.
  • Associated conditions include autoimmune disorders and lymphoproliferative disorders.
  • Common findings include splenomegaly, lymphadenopathy, lung opacities, and impaired T-cell function.

Conclusions:

  • Granulomatous disease is a significant complication of CVID, contributing to poor outcomes.
  • The etiology of granulomatous disease in CVID remains unknown.
  • Optimal treatment strategies for granulomatous disease in CVID are not yet established, necessitating further research.